Phenotypes in HGFAC-KO mice were consistent with liver-specific deletion of PPARγ, which results in reduced hepatic steatosis and impaired hepatic glucose homeostasis eventually leading to the development of peripheral insulin resistance (49, 50). This evidence concerns the gene PPARG and fatty liver disease.